Fight for Insulin Cost Cap; Hormone Predicts Osteoporosis; 3% Obesity Jump in 2020

News

The Endocrine Society released a statement praising proposed policy changes that would cap insulin costs at just $35 a month for patients.

Though not everyone is in favor. Voting “no” to this bill, Rep. Matt Gaetz (R-Fla.) argued that patients with diabetes should first have to lose weight. (USA Today)

A systematic review and meta-analysis of 18 studies found a 52.3% prevalence rate of diabetic retinopathy among pregnant women with preexisting type 1 or type 2 diabetes. (JAMA Ophthalmology)

Measuring levels of anti-Mullerian hormone may help pinpoint if menopause-related bone loss is already underway or about to happen. “To be able to intervene and reduce the rate and amount of bone loss, we need to know if this loss is imminent or already ongoing,” said lead study author Arun Karlamangla, MD, of the David Geffen School of Medicine at UCLA, in a statement. (Journal of Bone and Mineral Research)

Pairing artificial intelligence with abdominal CT imaging helped identify early indications of type 2 diabetes. (Radiology)

No surprise here: obesity rates rose by 3% during the COVID-19 pandemic compared with 2019. However, there was also a 4.4% increase in the rate of people engaging in monthly physical activity, as well. (American Journal of Preventive Medicine)

USC’s Keck Medicine announced a partnership with The TransLatin@ Coalition to bolster access to specialized care for the transgender, gender non-conforming, and intersex community.

Rhythm Pharmaceuticals announced it made some tweaks to its phase III EMANATE and ongoing phase II DAYBREAK trials of setmelanotide to focus on rare genetic obesity patient populations.

  • author['full_name']

    Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

Products You May Like

Articles You May Like

Biden’s comments about pandemic widen public health split over how US should respond to Covid-19
Viruses exploit ability to sense the environment to maximize their infective yield
Formula may be right for infants, but experts warn that toddlers don’t need it
Antibody Evolution Machine
The Covid-19 emergency may end, but there’s no rule to say when the pandemic is over

Leave a Reply

Your email address will not be published.